PSMA-PET in combination with CT has been reported to improve primary tumor localization [13] and the diagnosis of recurrent prostate cancer [14, 15] in patients after radical prostatectomy even at low PSA levels [16]. This evidence concerns the gene FOLH1 and Familial prostate cancer.